Week in Review: July 16 - Insights
Top highlights include: a third dose of COVID-19 vaccine sparking debate over booster shots, rare reactions with the J&J COVID-19 vaccine, and can vaccinated people get long Covid.
Industry Archives - Page 3 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
TRBC1 a Useful Tool in T-Cell Flow Cytometry [Test in Focus] - Insights
Horatiu Olteanu, M.D., Ph.D., gives an overview of the updated Leukemia and Lymphoma Immunophentoyping test now including TCRBC1 available through Mayo Clinic Laboratories.
6 Ways Individualized Medicine Is Advancing Patient Care - Insights
Keith Stewart, M.B., Ch.B., Carlson and Nelson Endowed Director, Mayo Clinic Center for Individualized Medicine, presented six ways precision medicine has further advanced into patient care over the past year.
People Archives - Page 28 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
The Adoption of Social Media in Education - Insights
Elissa Hall, Associate Director for Curriculum and Education Technology and an Assistant Professor at Mayo Clinic, discusses how the adoption of social media in education creates a flexible environment for facilitating collaborative, deeper...
Cardiovascular Events in Patients With or Without Coronary Artery Disease
A new type of blood test may help physicians identify which patients with and without evidence of coronary blockages are at risk for heart attacks and strokes. Even individuals with normal levels of low-density lipoprotein (LDL), known as...
Ceramides are lipids associated with atherosclerotic plaque formation, hypertension, insulin resistance, and obesity. Mayo Clinic Laboratories’ testing quantifies ceramides, providing an early indicator to help physicians predict heart...
A Test in Focus Archives - Page 7 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
New tests launched in October - Insights
In October 2022, Mayo Clinic Laboratories announced thirty new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Hereditary Alzheimer's disease and dementia - Insights
Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.
Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.
Learn more about how Mayo Clinic Laboratories’ testing can assist in diagnosis and differentiation of porphyrias and help guide treatment decisions
Learn more about educational offerings available to primary clients of Mayo Clinic Laboratories.
Precision therapeutics - Insights
At Mayo Clinic Laboratories, utilization of precision therapeutics, or pharmacogenomic testing used in conjunction with therapeutic drug monitoring, provides personalized insights to guide and monitor prescription medication use.
Learn more about how Mayo Clinic Laboratories’ unique testing for sphingolipidoses, including Gaucher and Krabbe diseases, can confirm diagnosis and guide disease management.
Including comprehensive panels and medication targeted assays, Mayo Clinic Laboratories pharmacogenomic testing focuses on clinically actionable genes and enables the detection of more alleles than other testing.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
CPT Codes and LOINC Update: June 2019 - Insights
View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of June 2019.
Week in Review: April 8 - Insights
Today's Highlights Include: 5 reasons to consider becoming an organ donor, why so many women in middle age are on antidepressants, and should you get a second COVID-19 vaccine booster?
Including carrier screening, molecular testing, and cytogenetic analysis, Mayo Clinic Laboratories prenatal evaluations provide vital insights for prospective and expecting parents.
Learn more Mayo Clinic Laboratories robust menu of newborn screening testing, which includes both primary and second-tier biochemical and molecular evaluations.
Lysosomal Storage Disease Panel by NGS [Test in Focus] - Insights
Devin Oglesbee, Ph.D., Director of the Biochemical and Molecular Genetics Laboratories at Mayo Clinic, provides an overview of the lysosomal storage disease panel, when it is appropriate to order this test, what actions the results allow...
MCL - Hematopathology/Cytogenetics Test Request Form T726 - MC0767-05A
MCL - Hematopathology/Cytogenetics Test Request Form T726
Training Clinical Laboratory Staff to Work at the Highest Level: Part 1 | Insights
Skip to Content MayoACCESS MayoLINK...
What's New in Health Care Reform: Feb. 20 - Insights
Top highlights include: Flu shot kept about 50% from going to doctor, racial disparities in cancer incidence and survival rates are narrowing, having anesthesia once as a baby does not cause learning disabilities, personalized diet predicts...
People Archives - Page 4 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Patient-focused pragmatism: The Mayo Clinic innovation model - Insights
In a world of ever-faster technical change, Mayo Clinic Laboratories is uniquely positioned to innovate. Collaboration with clinicians pinpoints unmet patient needs and facilitates the development of diagnostic testing that provides...
Renal Pathology at Mayo Clinic Laboratories
Mayo Clinic Laboratories’ is integrated with the Renal Biopsy Laboratory in the Department of Laboratory Medicine and Pathology at Mayo Clinic. Board-certified pathologist have a special interest in non-neoplastic disease of the kidney and...
Carbohydrate metabolism - Insights
Learn more about how Mayo Clinic Laboratories testing for carbohydrate metabolism can identify genetic variants and confirm diagnosis of these complex conditions.
New tests launched in January - Insights
In January 2022, Mayo Clinic Laboratories announced twenty five new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Demyelinating neuropathies - Insights
Learn how our expert-backed testing can increase confidence when it comes to the identification of several demyelinating neuropathies.
Demyelinating disease - Insights
Learn about our demyelinating disease testing, including multiple sclerosis, AQP4/MOG-associated disorders, and spinal cord disorders.
A new path forward: Hussein - Insights
For a young child diagnosed with inflammatory bowel disease, an unexpected turn of events led by results of a Mayo Clinic Laboratories test freed him and his family from the bonds of frequent medical visits and expensive treatment, and...
New tests launched in October - Insights
In October 2021, Mayo Clinic Laboratories announced eleven new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Skip to Content MayoACCESS MayoLINK...
December 2022 - Clinical Informatics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Informatics.
Future Direction of Lab Medicine - Insights
Looking into the future of laboratory medicine and pathology and providing insight into the direction its heading.
Hereditary Colon Cancer Testing - Mayo Clinic Laboratories
Our algorithmic approach aids with the ordering process and guides physicians to ensure the right tests are being ordered at the right time for patients.
Email Management and Tips - Insights
Opening your email inbox is like being dealt a hand of cards. You don’t know what you’ll get, you may be caught off guard, and you need to determine how to play out the hand you’ve been dealt. Thomas Huntley, MT(ASCP), Education...
Immunobullous Diseases: Paraneoplastic Pemphigus (PNP) - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss a rare and potentially fatal mucocutaneous blistering disease that is often associated with an underlying malignancy, called paraneoplastic pemphigus. She will also discuss the...
Learn about our hereditary cancer test offerings, including single-gene assays that evaluate specific genes already identified in a parent.
Learn more about how Mayo Clinic Laboratories’ genetic testing for pancreatic disease can provide a clearer understanding of a patient’s condition.
What's New in Health Care Reform: Dec. 26 - Insights
Top highlights include: FDA panel backs prescribing opioid overdose reversal drug along with painkillers, Surgeon General warns youth vaping is now an "epidemic," international patients seeking cures in the states, Mayo Clinic President and...
Mayo Clinic Labs @Work: Tim Brantner - Insights
Before he arrived at Mayo Clinic, Tim Brantner worked for a variety of organizations outside of health care. He joined Mayo Clinic Laboratories 14 years ago to help tell the labs’ story.
Mayo Clinic Laboratories’ commitment to pediatric care is supported by over 150 years of experience informing diagnoses and treatment plans.
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Shining light on one family's struggle: Barbara, Deborah, Pamela, and Rylie - Insights
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
Therapeutics events - Insights
TherapeuticS Creating the new standard of therapeutic management, together Mayo Clinic Laboratories’ evidence-based toxicology and pharmacogenomic testing
Yuma Regional Medical Center: Changing perceptions and powering growth - Insights
Looking to elevate laboratory operations, Yuma Regional’s hospital directors established a leadership model that pairs medical and administrative leaders, resulting in a changed perception of the laboratory’s ability to drive profitability...